Cardiac tyrosine hydroxylase activation and MB-COMT in dyskinetic monkeys

Area of Science:

• Neuroscience
• Cardiovascular Science
• Pharmacology

Background:

• Age-associated disorders, including cardiovascular and neurodegenerative diseases like Parkinson's, pose significant burdens.
• Parkinson's disease is linked to cardiovascular nervous system dysfunction, but cardiac roles require further study.
• Catecholamine metabolism in the heart is crucial for cardiovascular function and may be altered in Parkinson's.

Purpose of the Study:

• To investigate the impact of Parkinson's disease models on cardiac catecholamine metabolism.
• To analyze the expression of key proteins involved in catecholamine synthesis and metabolism in the heart.
• To elucidate the responsiveness of cardiac noradrenergic neurons in Parkinsonian models.

Main Methods:

• Analysis of the dopaminergic system in the nigrostriatal pathway of MPTP-intoxicated monkeys.
• Quantification of total and phosphorylated tyrosine hydroxylase (TH) in cardiac ventricles.
• Measurement of membrane-bound (MB) and soluble (S) catechol-O-methyl transferase (COMT) isoforms in the heart.

Main Results:

• MPTP intoxication depleted the nigrostriatal dopaminergic system.
• Decreased total TH expression was observed in the ventricles of MPTP- and MPTP+L-DOPA-treated monkeys.
• Increased phospho-TH was found in the left ventricle (LV) of both groups and the right ventricle (RV) of MPTP-treated monkeys.
• MB-COMT significantly increased in the LV of MPTP- and MPTP+L-DOPA-treated animals, suggesting enhanced noradrenaline metabolism.
• Cardiac noradrenergic neurons showed increased TH activity, indicating continued responsiveness.

Conclusions:

• MB-COMT is the primary isoform involved in cardiac noradrenergic changes post-MPTP treatment.
• MPTP treatment leads to increased cardiac noradrenaline metabolism.
• Cardiac noradrenergic neurons retain responsiveness despite neurotoxin-induced Parkinsonism.